Dr. Yihua Wang from the University of Southampton, a senior author on the paper said, "This research represents a pivotal ...

It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...

Dr Yihua Wang from the University of Southampton, a senior author on the paper said: "This research represents a pivotal advancement in our understanding of MYCN non-amplified neuroblastomas.

Dargeon 10 has recently reviewed all aspects of neuroblastomas in children, and his review indicates that no single chemotherapeutic agent or combination has been uniformly effective. Many ...

"These are very exciting results that hopefully get us closer to finding treatments for children who develop neuroblastomas. "Currently, the outcomes are really poor for children who get this ...